This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Common semaglutide side effects include nausea, vomiting, ...

Researchers analyzing U.S. safety reports say certain medications containing semaglutide may be linked to a rare eye ...

GLP-1 drugs like (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many people with ...

Semaglutide, in any formulation, was the only agent significantly associated with eye stroke, with the strongest signal for Wegovy, followed by Ozempic. Men were found to be 3 times more at risk than ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Taking semaglutide while breastfeeding isn’t currently advised. More research is needed to know if it’s safe. If you’re taking semaglutide for type 2 diabetes, your healthcare provider can let you ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

NAION is often referred to as an ‘eye stroke’, it causes sudden, painless vision loss - usually in one eye, but sometimes in both eyes.

Greater willingness to continue treatment seen with effective weight loss, even when accompanied by gastrointestinal side effects.

UAB researchers report that the oral drug TIX100 prevented weight regain after stopping semaglutide in preclinical studies. The findings suggest a potential non‑GLP‑1 therapy to maintain weight loss ...

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.